Investigation into the pharmacodynamics and pharmacokinetics of recombinant human interferon alfa-2b vaginal suppository following process optimization in chinese rhesus macaque. [PDF]
Sci RepZhang X, Zhou B, Gong Y, Liu Y.
europepmc +1 more source
Organizing pneumonia in a patient following treatment of chronic hepatitis B with pegylated interferon alfa-2b: A case report. [PDF]
IDCasesTian B, Wang P, Shan C, Gao C, Zhang Q.
europepmc +1 more source
Hepatitis C, interferon alfa, and depression [PDF]
Hepatology, 2000 D, Zdilar +4 more
openaire +2 more sources
DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera. [PDF]
BloodAbu-Zeinah G +8 more
europepmc +1 more source
Autoanticuerpos en pacientes hematológicos tratados con interferón alfa
Revista Cubana de Hematología, Inmunología y HemoterapiaSe estudió la presencia de autoanticuerpos en 45 pacientes con enfermedades hematológicas: 32 con leucemia mieloide crónica (LMC) y 13 con otras enfermedades linfoproliferativas (ELP).
Antonio A Bencomo Hernández +5 more
doaj
Combination therapy with ruxolitinib and pegylated interferon alfa-2a in newly diagnosed patients with polycythemia vera. [PDF]
Blood AdvSørensen AL +13 more
europepmc +1 more source
[Clinical effect and influencing factors of pegylated interferon alfa-2a and entecavir monotherapy among children with HBeAg-positive chronic hepatitis B based on a real-world study]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2022 Wang HM +7 more
europepmc +1 more source
[A case of chronic hepatitis B who achieved clinical cure with pegylated interferon alfa intermittent and combination therapy]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang SY, Deng W, Li MH.
europepmc +1 more source